These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 30332560)

  • 1. Type I Interferons in Autoimmune Disease.
    Crow MK; Olferiev M; Kirou KA
    Annu Rev Pathol; 2019 Jan; 14():369-393. PubMed ID: 30332560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon in the pathogenesis of lupus.
    Crow MK
    J Immunol; 2014 Jun; 192(12):5459-68. PubMed ID: 24907379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in understanding the role of type I interferons in systemic lupus erythematosus.
    Crow MK
    Curr Opin Rheumatol; 2014 Sep; 26(5):467-74. PubMed ID: 25010440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
    Baccala R; Hoebe K; Kono DH; Beutler B; Theofilopoulos AN
    Nat Med; 2007 May; 13(5):543-51. PubMed ID: 17479100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic associations in type I interferon related pathways with autoimmunity.
    Delgado-Vega AM; Alarcón-Riquelme ME; Kozyrev SV
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S2. PubMed ID: 20392289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Toll like receptor-activated dendritic cells in the development of autoimmunity.
    Granucci F; Zanoni I
    Front Biosci; 2008 May; 13():4817-26. PubMed ID: 18508547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
    Wenzel J; Zahn S; Bieber T; Tüting T
    Arch Dermatol Res; 2009 Jan; 301(1):83-6. PubMed ID: 18784932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
    López de Padilla CM; Niewold TB
    Gene; 2016 Jan; 576(1 Pt 1):14-21. PubMed ID: 26410416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type I interferon system in the development of lupus.
    Rönnblom L; Alm GV; Eloranta ML
    Semin Immunol; 2011 Apr; 23(2):113-21. PubMed ID: 21292501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fueling autoimmunity: type I interferon in autoimmune diseases.
    Di Domizio J; Cao W
    Expert Rev Clin Immunol; 2013 Mar; 9(3):201-10. PubMed ID: 23445195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.
    Mangini AJ; Lafyatis R; Van Seventer JM
    Ann N Y Acad Sci; 2007 Jun; 1108():11-23. PubMed ID: 17893966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of type I interferon in systemic autoimmune diseases.
    Crow MK; Olferiev M; Kirou KA
    Transl Res; 2015 Feb; 165(2):296-305. PubMed ID: 25468480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease.
    Crow MK
    Autoimmunity; 2010 Feb; 43(1):7-16. PubMed ID: 19961365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Nucleic Acid Detection in Autoimmunity.
    Crowl JT; Gray EE; Pestal K; Volkman HE; Stetson DB
    Annu Rev Immunol; 2017 Apr; 35():313-336. PubMed ID: 28142323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Type I Interferonopathies.
    Lee-Kirsch MA
    Annu Rev Med; 2017 Jan; 68():297-315. PubMed ID: 27813875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.
    Pollard KM; Escalante GM; Huang H; Haraldsson KM; Hultman P; Christy JM; Pawar RD; Mayeux JM; Gonzalez-Quintial R; Baccala R; Beutler B; Theofilopoulos AN; Kono DH
    J Immunol; 2017 Dec; 199(11):3739-3747. PubMed ID: 29055005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetics of systemic lupus erythematosus: A comprehensive review.
    Ghodke-Puranik Y; Niewold TB
    J Autoimmun; 2015 Nov; 64():125-36. PubMed ID: 26324017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.